Assert-IQ vs Eko Foundation Analysis Software with Transformers (EFAST)
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if your patient requires long-term, continuous cardiac monitoring (up to 6 years) to diagnose infrequent or asymptomatic arrhythmias that may not be captured during shorter observation periods. This system is ideal for comprehensive arrhythmia detection and remote management, providing proactive alerts and patient-activated symptom logging for a complete diagnostic picture.
View Assert-IQ →Choose Eko Foundation Analysis Software with Transformers (EFAST) if…
Choose EFAST if you need real-time, AI-powered cardiac insights during routine physical examinations, particularly for immediate detection of structural murmurs and atrial fibrillation. This tool enhances auscultation with advanced audio and waveform visualization, streamlining the diagnostic process directly at the point of care and integrating seamlessly with EMR systems.
View Eko Foundation Analysis Software with Transformers (EFAST) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Assert-IQ | Eko Foundation Analysis Software with Transformers (EFAST) |
|---|---|---|
| Pricing | Enterprise | Subscription-based, contact for details |
| Deployment | Hybrid | Cloud-based Software as a Medical Device (SaMD) |
| FDA Status | Cleared AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Foundation Analysis Software with Transformers (EFAST)EFAST offers a more immediate and interactive user experience for clinicians during routine exams with real-time AI analysis, waveform visualization, and guided exams. Assert-IQ's usability for clinicians primarily involves accessing a cloud platform for data retrieval from an implanted device, with patient interaction via an activator.
Clinical Value
Eko Foundation Analysis Software with Transformers (EFAST)EFAST provides specific, high-performance metrics for its real-time AI detection of structural murmurs (93% sensitivity, 91% specificity) and AFib (95% sensitivity, 94% specificity), offering immediate, actionable insights during routine exams. Assert-IQ's value lies in its extended, continuous monitoring for intermittent arrhythmias, which serves a different clinical need without providing specific performance metrics in the provided data.
Pricing & Value
Eko Foundation Analysis Software with Transformers (EFAST)EFAST offers a more transparent and accessible pricing model with a subscription option, a free trial included with stethoscope purchase, and an estimated daily cost for the stethoscope technology. Assert-IQ's enterprise pricing requires direct contact for institutional pricing, suggesting a less transparent and potentially higher barrier to entry.
Enterprise Readiness
Assert-IQAssert-IQ, backed by Abbott Medical, explicitly targets large health systems, hospitals, and cardiology clinics, and offers hybrid deployment, indicating robust infrastructure and established support for enterprise-level deployments. While EFAST is also enterprise-ready with EMR integration and cloud deployment, Abbott's scale and long history in complex medical devices provide a stronger foundation for large-scale adoption and support.
Innovation
Eko Foundation Analysis Software with Transformers (EFAST)EFAST innovates by integrating high-performance AI directly into the routine auscultation process, providing real-time, actionable insights at the point of care, transforming a traditional diagnostic method. Assert-IQ's innovation is in extending the duration (up to 6 years) and sophistication of continuous implantable cardiac monitoring, which is also significant but in a different diagnostic context.
Support & Docs
TieBoth Abbott Medical and Eko Health are reputable companies expected to provide adequate support and documentation for their medical devices. Without specific comparative data on the quality, breadth, or responsiveness of their support for these particular products, it is not possible to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | Eko Foundation Analysis Software with Transformers (EFAST) |
|---|---|---|
| Name | Assert-IQ | Eko Foundation Analysis Software with Transformers (EFAST) |
| Company | Abbott Medical | Eko Health |
| Primary Function | Long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | Advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. |
| Key Detection Focus | Advanced arrhythmia detection | Structural murmurs and atrial fibrillation (AFib) detection |
| Monitoring/Analysis Duration | Long-term continuous cardiac monitoring (up to 6 years) | Real-time AI analysis during auscultation |
| Mobile App | None | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and Eko Foundation Analysis Software with Transformers (EFAST).
Frequently Asked Questions
More Comparisons
More matchups featuring Assert-IQ or Eko Foundation Analysis Software with Transformers (EFAST)
- Eko Foundation Analysis Software with Transformers (EFAST) vs Sleepiz One+
- Eko Foundation Analysis Software with Transformers (EFAST) vs EchoNext
- Eko Foundation Analysis Software with Transformers (EFAST) vs Cardiomo
- Eko Foundation Analysis Software with Transformers (EFAST) vs PMcardio
- Assert-IQ vs EchoNext
- Assert-IQ vs PMcardio
Backers
Who funded each tool's parent company.